Latest edition: 23 September 2025
Latest edition: 23 September 2025
Metsera, which went public in January this year, could provide Pfizer with strong growth drivers in the obesity treatment arena.
Though Keytruda QLEX will be more patient-centric, analysts are sceptical of the drug’s capacity to stave off generic competition.
Bill Gates has also called on governments to reverse global health funding cuts.
The two companies will leverage automation, data and AI to streamline drug discovery, development and manufacturing.
The approval is based on findings from the pivotal Phase III INDIGO study.
Alternative treatments for mental health conditions are useful add-ons, but they are unlikely to represent a sea change in how mental health is addressed.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
